Sponsors

RECENT NEWS

NHS BRCA genetic testing programme identifies hundreds with increased cancer risk

Hundreds of people with Jewish ancestry in England have been identified as at increased risk of cancer and offered risk-reducing options, as part of a new NHS genetic testing programme.

New distribution agreement for BIOHIT

BIOHIT has reached an agreement with Biomedal to supply its iVYLISA, iVYCHECK and GlutenDetect gluten immunogenic peptide (GIP) tests.

MHRA publishes guidance on new medical devices post-market surveillance requirements

The Medicines and Healthcare products Regulatory Agency (MHRA) has published new guidance for medical device manufacturers ahead of the new Post-market surveillance (PMS) regulation for medical devices in Great Britain (GB) which will come into force this summer.

Blood test developed to allow early detection of multiple cancers

Researchers at the University of Oxford have unveiled a new blood test – powered by machine learning – which shows real promise in detecting multiple types of cancer in their earliest stages, when the disease is hardest to detect.

Aignostics publishes results for pathology foundation model

Aignostics has announced research results for a new pathology foundation model developed in collaboration with Mayo Clinic Digital Pathology. The model, built in two months using 1.2 million diverse slide images from Mayo Clinic and Charité – Universitätsmedizin Berlin, establishes a new state-of-the-art for performance across more than twenty public benchmarks.

New partnership to advance sequencing-based IVD neonatal testing

Revvity has announced a strategic agreement to commercialise an in vitro diagnostic (IVD) workflow solution for neonatal sequencing, co-developed with Element Biosciences, a life science company democratising access to advanced DNA and multi-omic sequencing solutions.

Proscia’s growth more than doubles as customers adopt enterprise pathology

AI-enabled pathology solutions company Proscia more than doubled its growth in 2024, it has announced. The company enters 2025 having cemented its leadership position, with life sciences organisations and diagnostic laboratories increasingly deploying its Concentriq enterprise pathology platform to advance the next novel therapies and diagnostics.

Biofidelity and CellCarta partner to deploy Aspyre Lung in global clinical trials

Biofidelity, a leader in innovative genomic solutions, and contract research organisation CellCarta, have announced a strategic partnership agreement to utilise Biofidelity’s Aspyre Lung in global clinical trials.

Major update at SWLP’s Croydon laboratory

South West London Pathology (SWLP) has celebrated the installation of new cutting-edge technology from Beckman Coulter at its Essential Services Laboratory at Croydon Hospital, creating one of the most modern, innovative, and efficient clinical blood science services in the country.

IBMS responds to government’s Elective Care Reform Plan

The Institute of Biomedical Science (IBMS) has published a response to the government’s newly published ‘Reforming elective care for patients’, saying that investing in diagnostic capacity, digital transformation, and a robust biomedical science workforce is essential to delivering faster, more equitable elective care for all.

New partnership to bring novel neurological diagnostics to the NHS

Next generation testing, artificial intelligence, advanced mass spectrometry and machine learning will be used to bring new diagnostics to NHS patients, thanks to a new partnership between University College London Hospitals NHS Foundation Trust (UCLH) and Guilford Street Laboratories (GSL).

Leica Biosystems and Indica Labs announce strategic investment

Leica Biosystems has agreed to make a significant strategic investment in Indica Labs, the two pathology firms have announced. This partnership aims to accelerate AI-enabled companion diagnostics and will also create a new digital pathology platform.

New platelet counting technology to help laboratories prevent diagnosis errors

Risks that can lead to errors in cancer diagnoses could be reduced, as just one benefit of high precision platelet counting technology, launched by international health technology company Mindray.

Bio-Rad leads investment to support gastrointestinal diagnostics

Diagnostics firm Geneoscopy has announced new funding of $105 million, led by Bio-Rad Laboratories, to support the launch of non-invasive colorectal cancer screening test ColoSense, and advance diagnostic innovations for inflammatory bowel disease.

Herpes virus might drive Alzheimer’s pathology, study suggests

University of Pittsburgh researchers uncovered a surprising link between Alzheimer’s disease and herpes simplex virus-1 (HSV-1), suggesting that viral infections may play a role in the disease.

Novel ‘suspended animation’ blood draw technique

Scientists at the Allen Institute have developed a new approach that keeps blood cells alive in deep freeze, with this new technique promising to expand the reach of cutting-edge single-cell technologies to underserved populations.

New AI tool uses routine blood tests to predict immunotherapy response for many cancers

A recently published study shows that a new blood test combined with an AI tool can better predict if individual cancer patients will benefit from immune checkpoint inhibitors, a type of immunotherapy treatment.

New genetic material for validating H5N1 bird influenza diagnostic tests

The USA’s National Institute of Standards and Technology (NIST) has developed a synthetic, non-hazardous genetic material to support the development and validation of diagnostic tests for the H5N1 virus - commonly known as bird influenza.

Anthony Harnden takes up position as MHRA Chair

Professor Anthony Harnden has taken up the position as Chair of the Medicine and Healthcare products Regulatory Agency (MHRA), from January 2025.

Government expanding CDCs to tackle NHS waiting lists

Prime Minister Sir Keir Starmer has unveiled the government’s Elective Reform Plan, which aims to end NHS backlogs by offering up to half a million more appointments each year thanks to greater access to Community Diagnostic Centres and new or expanded surgical hubs.

Latest Issues

UKHSA Conference 2025

Manchester Central
25-26 March, 2025

Microbiology Society Annual Conference 2025

Liverpool Arena and Convention Centre
31 March - 3 April, 2025

2nd Global Summit on Pathology

Rome, Italy
10-11 April, 2025

Clinical Innovations EXPO - Breaking Through the Adoption Barriers

Jubilee Hotel and Conference Centre, Nottingham, UK
15 May, 2025

BSMT Annual Microbiology Conference

RAF Museum, Hendon, London NW9 5LL
15 May, 2025